BVF as of Sept. 30, 2015
Portfolio Holdings for BVF
BVF holds 27 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 10.3 | $51M | 4.9M | 10.42 | |
| Chemocentryx | 9.3 | $46M | 7.6M | 6.05 | |
| Oncothyreon | 9.1 | $45M | 16M | 2.74 | |
| Array BioPharma | 8.9 | $44M | 9.7M | 4.56 | |
| Concert Pharmaceuticals I equity | 8.6 | $42M | 2.3M | 18.77 | |
| Blueprint Medicines (BPMC) | 7.3 | $36M | 1.7M | 21.34 | |
| Exelixis Inc cnv | 6.7 | $33M | 27M | 1.21 | |
| Loxo Oncology | 5.4 | $27M | 1.5M | 17.48 | |
| Vitae Pharmaceuticals | 5.3 | $26M | 2.4M | 11.01 | |
| Forward Pharma A/s | 4.8 | $24M | 1.0M | 23.56 | |
| Oncomed Pharmaceuticals | 4.6 | $23M | 1.4M | 16.59 | |
| Cti Biopharma | 3.0 | $15M | 10M | 1.46 | |
| Cytokinetics (CYTK) | 2.9 | $14M | 2.1M | 6.69 | |
| ArQule | 2.5 | $12M | 6.6M | 1.87 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 2.3 | $11M | 1.2M | 9.66 | |
| Qlt | 2.0 | $9.9M | 3.7M | 2.66 | |
| Xenon Pharmaceuticals (XENE) | 1.7 | $8.6M | 1.0M | 8.26 | |
| GTx | 1.6 | $8.2M | 11M | 0.76 | |
| Catalyst Biosciences | 1.0 | $4.8M | 1.0M | 4.66 | |
| Mast Therapeutics | 0.6 | $3.0M | 5.1M | 0.58 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.5 | $2.5M | 2.5M | 0.99 | |
| Calithera Biosciences | 0.5 | $2.5M | 457k | 5.43 | |
| Sunesis Pharmaceuticals | 0.4 | $2.0M | 2.5M | 0.81 | |
| Globeimmune (GBIM) | 0.4 | $1.8M | 678k | 2.61 | |
| Pain Therapeutics | 0.3 | $1.7M | 929k | 1.83 | |
| Biota Pharmaceuticals | 0.1 | $695k | 351k | 1.98 | |
| Aptose Biosciences | 0.0 | $179k | 42k | 4.30 |
